Ironwood Pharmaceuticals announced an agreement with Allergan plc for the US co-promotion of Viberzi (eluxadoline), Allergan’s new treatment for adults...
Actavis plc announced that Viberzi (eluxadoline) was approved by the FDA as a twice-daily, oral treatment for adults suffering from...
Allergan plc , has announced that Viberzi (eluxadoline), the company's first-in-class treatment for irritable bowel syndrome with diarrhea (IBS-D), is...
- Allergan plc announced the publication of the positive results of the Phase III trials of Viberzi IV (eluxadoline) for...